Vimarsana
Biggest News Aggregation in the World

Page 6 - Multicenter Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Multicenter Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Multicenter Study Today - Breaking & Trending Today

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Invest - Vimarsana News

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Invest

− First results from LIGHTHOUSE trial presented at 23rd Annual Scientific Meeting in Urologic Oncology (SUO) –MONROE TOWNSHIP, N.J. & OXFORD, England--(BUSINESS WIRE)--Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative PET radiopharmaceuticals, today...

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer - Vimarsana News

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

- First results from LIGHTHOUSE trial presented at 23rd Annual Scientific Meeting in Urologic Oncology (SUO) - Blue Earth Diagnostics, a Bracco company and recognized leader in the development and

Without Guidelines, Docs Make Their Own Long COVID Protocols - Vimarsana News

Without Guidelines, Docs Make Their Own Long COVID Protocols

Diagnosing long COVID is something of an art for doctors who, without any formal criteria, say they know it when they see it.

Nektar Therapeutics Reports Third Quarter 2022 Financial Results - Vimarsana News

Nektar Therapeutics Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2022. Cash and investments in...

Nektar Therapeutics Reports Third Quarter 2022 Financial Results - Vimarsana News

Nektar Therapeutics Reports Third Quarter 2022 Financial Results

/PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2022. Cash and investments in...